AAAAAA
Results:
1-7
|
Results: 7
Authors:
LERNER AG
OYFFE I
SIGAL M
Citation: Ag. Lerner et al., NALTREXONE-INDUCED REDUCTION OF TOBACCO INTAKE, The Journal of clinical psychiatry, 59(1), 1998, pp. 30-31
Authors:
FINKEL B
LERNER AG
OYFFE I
SIGAL M
Citation: B. Finkel et al., RISPERIDONE-ASSOCIATED AGRANULOCYTOSIS, The American journal of psychiatry, 155(6), 1998, pp. 855-856
Authors:
LERNER AG
FINKEL B
OYFFE I
MERENZON I
SIGAL M
Citation: Ag. Lerner et al., CLONIDINE TREATMENT FOR HALLUCINOGEN PERSISTING PERCEPTION DISORDER, The American journal of psychiatry, 155(10), 1998, pp. 1460-1460
Authors:
LERNER AG
GELKOPF M
SIGAL M
OYFFE I
Citation: Ag. Lerner et al., INDICATORS OF GOOD PROGNOSIS IN NALTREXONE TREATMENT - A 5-YEAR PROSPECTIVE-STUDY, Addiction research, 4(4), 1997, pp. 385-391
Authors:
LERNER AG
OYFFE I
ISAACS G
SIGAL M
Citation: Ag. Lerner et al., NALTREXONE TREATMENT OF HALLUCINOGEN PERSISTING PERCEPTION DISORDER, The American journal of psychiatry, 154(3), 1997, pp. 437-437
Authors:
LERNER AG
GELKOPF M
OYFFE I
SIGAL M
Citation: Ag. Lerner et al., HOME-BASED INPATIENT TREATMENT VS OUTPATIENT DAY CLINIC TREATMENT - APRELIMINARY-REPORT IN OPIATE-DEPENDENT PATIENTS, The Journal of nervous and mental disease, 183(11), 1995, pp. 715-715
Authors:
LERNER AG
SIGAL M
GELKOPF M
Citation: Ag. Lerner et al., NALTREXONE ABUSE AND RISK OF SUICIDE, The Journal of nervous and mental disease, 181(11), 1993, pp. 706-707
Risultati:
1-7
|